Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124072 | SCV000167481 | benign | not specified | 2012-04-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000254163 | SCV000318436 | likely benign | Cardiovascular phenotype | 2016-12-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000474191 | SCV000562919 | benign | Long QT syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000124072 | SCV001159445 | benign | not specified | 2019-03-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003390811 | SCV004129713 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | CACNA1C: BP4, BP7, BS1 |